https://www.fiercepharma.com/pharma/eli-lilly-slapped-third-fda-rejection-2023-time-eczema-treatment-lebrikizumab
0
0
Eli Lilly slapped with third FDA rejection in 2023, this time for eczema treatment lebrikizumab - FiercePharma
10/2/23 at 3:06pm
Organization
FiercePharma
Author
FiercePharma
Details
16 words
Summarize
Create an account or login to join the discussion